With professional guidance and realistic expectations, GLP-1 weight loss can be a valuable tool for those seeking a more effective and sustainable approach to managing their weight
In our cohort, patients starting treatment with oral semaglutide had lower weight and BMI, but were older than those included in the OW semaglutide group, who, by contrast, already had obesity-related complications (hypertension, steatosis, albuminuria) at baseline, albeit with a shorter disease duration
Reddyhoff, D., Ward, J., Williams, D., Regan, S
Researchers hypothesize that this peptide may influence pathways related to cellular signaling, vascular activity, and structural organization within experimental systems